{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:09:33Z","timestamp":1790514573617,"version":"4.1.0"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Virology"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.coviro.2015.03.001","type":"journal-article","created":{"date-parts":[[2015,3,29]],"date-time":"2015-03-29T16:00:32Z","timestamp":1427644832000},"page":"89-97","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Lessons from Reverse Vaccinology for viral vaccine design"],"prefix":"10.1016","volume":"11","author":[{"given":"Luca","family":"Bruno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirko","family":"Cortese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rino","family":"Rappuoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Merola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coviro.2015.03.001_bib0415","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/08998280.2005.11928028","article-title":"Edward Jenner and the history of smallpox and vaccination","volume":"18","author":"Riedel","year":"2005","journal-title":"Proc Bayl Univ Med Cent"},{"key":"10.1016\/j.coviro.2015.03.001_sbref0420","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/emmm.201403876","article-title":"Vaccines for the 21st century","volume":"6","author":"Delany","year":"2014","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.coviro.2015.03.001_bib0425","first-page":"419","article-title":"Genome-based bacterial vaccines: current state and future outlook","volume":"27","author":"Schubert-Unkmeir","year":"2013","journal-title":"BioDrugs Clin Immunother Biopharm Gene Ther"},{"key":"10.1016\/j.coviro.2015.03.001_bib0430","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1126\/science.7542800","article-title":"Whole-genome random sequencing and assembly of Haemophilus influenzae Rd","volume":"269","author":"Fleischmann","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.coviro.2015.03.001_bib0435","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1126\/science.287.5459.1816","article-title":"Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing","volume":"287","author":"Pizza","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.coviro.2015.03.001_bib0440","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1126\/science.287.5459.1809","article-title":"Complete genome sequence of Neisseria meningitidis serogroup B strain MC58","volume":"287","author":"Tettelin","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.coviro.2015.03.001_bib0445","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3389\/fimmu.2014.00012","article-title":"Designing vaccines for the twenty-first century society","volume":"5","author":"Finco","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.coviro.2015.03.001_bib0450","doi-asserted-by":"crossref","first-page":"10834","DOI":"10.1073\/pnas.0603940103","article-title":"A universal vaccine for serogroup B meningococcus","volume":"103","author":"Giuliani","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2015.03.001_bib0455","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2217\/imt.14.11","article-title":"Use of a multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) for bacterial meningitis prevention","volume":"6","author":"Esposito","year":"2014","journal-title":"Immunotherapy"},{"key":"10.1016\/j.coviro.2015.03.001_bib0460","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1126\/science.2523562","article-title":"Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome","volume":"244","author":"Choo","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.coviro.2015.03.001_bib0465","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1073\/pnas.88.6.2451","article-title":"Genetic organization and diversity of the hepatitis C virus","volume":"88","author":"Choo","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2015.03.001_bib0470","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1073\/pnas.91.4.1294","article-title":"Vaccination of chimpanzees against infection by the hepatitis C virus","volume":"91","author":"Choo","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2015.03.001_bib0475","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1126\/science.1114016","article-title":"Complete replication of hepatitis C virus in cell culture","volume":"309","author":"Lindenbach","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.coviro.2015.03.001_bib0480","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/nm1268","article-title":"Production of infectious hepatitis C virus in tissue culture from a cloned viral genome","volume":"11","author":"Wakita","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.coviro.2015.03.001_bib0485","doi-asserted-by":"crossref","first-page":"13950","DOI":"10.1073\/pnas.0506758102","article-title":"Genome analysis of multiple pathogenic isolates of Streptococcus agalactiae: implications for the microbial \u201cpan-genome\u201d","volume":"102","author":"Tettelin","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2015.03.001_bib0490","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000235761","article-title":"The bacterial pan-genome and reverse vaccinology","volume":"6","author":"Tettelin","year":"2009","journal-title":"Genome Dyn"},{"key":"10.1016\/j.coviro.2015.03.001_bib0495","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1126\/science.1109869","article-title":"Identification of a universal Group B streptococcus vaccine by multiple genome screen","volume":"309","author":"Maione","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.coviro.2015.03.001_bib0500","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.3390\/v3101800","article-title":"Next-generation dengue vaccines: novel strategies currently under development","volume":"3","author":"Durbin","year":"2011","journal-title":"Viruses"},{"key":"10.1016\/j.coviro.2015.03.001_bib0505","doi-asserted-by":"crossref","first-page":"7286","DOI":"10.1128\/JVI.00038-14","article-title":"Within-host whole-genome deep sequencing and diversity analysis of human respiratory syncytial virus infection reveals dynamics of genomic diversity in the absence and presence of immune pressure","volume":"88","author":"Grad","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2015.03.001_bib0510","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1146\/annurev-genom-091212-153406","article-title":"Deep sequencing of HIV: clinical and research applications","volume":"15","author":"Chabria","year":"2014","journal-title":"Annu Rev Genomics Hum Genet"},{"issue":"Suppl. 5","key":"10.1016\/j.coviro.2015.03.001_bib0515","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1186\/1471-2105-7-S5-S4","article-title":"Large-scale analysis of antigenic diversity of T-cell epitopes in dengue virus","volume":"7","author":"Khan","year":"2006","journal-title":"BMC Bioinform"},{"key":"10.1016\/j.coviro.2015.03.001_sbref0520","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1126\/science.1227919","article-title":"Decoding human cytomegalovirus","volume":"338","author":"Stern-Ginossar","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.coviro.2015.03.001_bib0525","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3389\/fmicb.2014.00218","article-title":"Functional annotation of human cytomegalovirus gene products: an update","volume":"5","author":"Van Damme","year":"2014","journal-title":"Front Microbiol"},{"key":"10.1016\/j.coviro.2015.03.001_bib0530","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.coviro.2014.08.001","article-title":"Human cytomegalovirus intrahost evolution\u2014a new avenue for understanding and controlling herpesvirus infections","volume":"8","author":"Renzette","year":"2014","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.coviro.2015.03.001_bib0535","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1126\/science.1243283","article-title":"Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus","volume":"342","author":"McLellan","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.coviro.2015.03.001_bib0540","doi-asserted-by":"crossref","first-page":"e70318","DOI":"10.1371\/journal.pone.0070318","article-title":"Inter- and intra-host viral diversity in a large seasonal DENV2 outbreak","volume":"8","author":"Romano","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.coviro.2015.03.001_bib0545","doi-asserted-by":"crossref","first-page":"8546","DOI":"10.1128\/JVI.00736-12","article-title":"Genome-wide patterns of intrahuman dengue virus diversity reveal associations with viral phylogenetic clade and interhost diversity","volume":"86","author":"Parameswaran","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2015.03.001_bib0550","first-page":"218590","article-title":"Emerging vaccine informatics","volume":"2010","author":"He","year":"2010","journal-title":"J Biomed Biotechnol"},{"key":"10.1016\/j.coviro.2015.03.001_bib0555","doi-asserted-by":"crossref","first-page":"D1124","DOI":"10.1093\/nar\/gkt1133","article-title":"Updates on the web-based VIOLIN vaccine database and analysis system","volume":"42","author":"He","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.coviro.2015.03.001_bib0560","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/978-1-62703-342-8_8","article-title":"Databases and in silico tools for vaccine design","volume":"993","author":"He","year":"2013","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.coviro.2015.03.001_bib0565","doi-asserted-by":"crossref","first-page":"D289","DOI":"10.1093\/nar\/gkh098","article-title":"VirGen: a comprehensive viral genome resource","volume":"32","author":"Kulkarni-Kale","year":"2004","journal-title":"Nucleic Acids Res"},{"issue":"Suppl. 5","key":"10.1016\/j.coviro.2015.03.001_bib0570","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1186\/1471-2105-7-S5-S12","article-title":"Curation of viral genomes: challenges, applications and the way forward","volume":"7","author":"Kulkarni-Kale","year":"2006","journal-title":"BMC Bioinform"},{"key":"10.1016\/j.coviro.2015.03.001_bib0575","doi-asserted-by":"crossref","first-page":"297505","DOI":"10.1155\/2010\/297505","article-title":"Vaxign: the first web-based vaccine design program for reverse vaccinology and applications for vaccine development","volume":"2010","author":"He","year":"2010","journal-title":"J Biomed Biotechnol"},{"issue":"Suppl. 4","key":"10.1016\/j.coviro.2015.03.001_sbref0580","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/1471-2105-14-S4-S2","article-title":"Genome-wide prediction of vaccine targets for human herpes simplex viruses using Vaxign reverse vaccinology","volume":"14","author":"Xiang","year":"2013","journal-title":"BMC Bioinform"},{"key":"10.1016\/j.coviro.2015.03.001_bib0585","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1089\/aid.1997.13.529","article-title":"An interactive Web site providing major histocompatibility ligand predictions: application to HIV research","volume":"13","author":"De Groot","year":"1997","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.coviro.2015.03.001_bib0590","doi-asserted-by":"crossref","first-page":"6471","DOI":"10.1016\/j.vaccine.2009.06.018","article-title":"In silico-accelerated identification of conserved and immunogenic variola\/vaccinia T-cell epitopes","volume":"27","author":"Moise","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2015.03.001_bib0595","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.vaccine.2010.10.064","article-title":"VennVax, a DNA-prime, peptide-boost multi-T-cell epitope poxvirus vaccine, induces protective immunity against vaccinia infection by T cell response alone","volume":"29","author":"Moise","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2015.03.001_bib0600","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1146\/annurev-micro-092412-155654","article-title":"An inquiry into the molecular basis of HSV latency and reactivation","volume":"67","author":"Roizman","year":"2013","journal-title":"Annu Rev Microbiol"},{"key":"10.1016\/j.coviro.2015.03.001_bib0605","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.coviro.2014.02.006","article-title":"Status of prophylactic and therapeutic genital herpes vaccines","volume":"6","author":"Awasthi","year":"2014","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.coviro.2015.03.001_bib0610","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1099\/vir.0.79888-0","article-title":"Genetic content of wild-type human cytomegalovirus","volume":"85","author":"Dolan","year":"2004","journal-title":"J Gen Virol"},{"key":"10.1016\/j.coviro.2015.03.001_bib0615","first-page":"63","article-title":"Cytomegalovirus cell tropism","volume":"325","author":"Sinzger","year":"2008","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.coviro.2015.03.001_bib0620","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.coviro.2012.01.001","article-title":"Human cytomegalovirus entry into cells","volume":"2","author":"Vanarsdall","year":"2012","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.coviro.2015.03.001_bib0625","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1365-2249.2007.03454.x","article-title":"Translational mini-review series on infectious disease: congenital cytomegalovirus infection: 50 years on","volume":"149","author":"Hassan","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.coviro.2015.03.001_bib0630","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/infdis\/171.1.26","article-title":"Immunity induced by primary human cytomegalovirus infection protects against secondary infection among women of childbearing age","volume":"171","author":"Adler","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2015.03.001_bib0635","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1001\/jama.289.8.1008","article-title":"Maternal immunity and prevention of congenital cytomegalovirus infection","volume":"289","author":"Fowler","year":"2003","journal-title":"JAMA"},{"issue":"Suppl. 1","key":"10.1016\/j.coviro.2015.03.001_bib0640","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/S0378-3782(14)70011-8","article-title":"Role of human cytomegalovirus (HCMV)-specific antibody in HCMV-infected pregnant women","volume":"90","author":"Revello","year":"2014","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.coviro.2015.03.001_bib0645","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1128\/JVI.64.3.1079-1085.1990","article-title":"Cell surface expression of human cytomegalovirus (HCMV) gp55-116 (gB): use of HCMV-recombinant vaccinia virus-infected cells in analysis of the human neutralizing antibody response","volume":"64","author":"Britt","year":"1990","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2015.03.001_bib0650","doi-asserted-by":"crossref","first-page":"11881","DOI":"10.1128\/JVI.74.24.11881-11892.2000","article-title":"Complex formation by human cytomegalovirus glycoproteins M (gpUL100) and N (gpUL73)","volume":"74","author":"Mach","year":"2000","journal-title":"J Virol"},{"issue":"Pt 7","key":"10.1016\/j.coviro.2015.03.001_bib0655","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1099\/0022-1317-77-7-1537","article-title":"Glycoprotein H of human cytomegalovirus is a major antigen for the neutralizing humoral immune response","volume":"77","author":"Urban","year":"1996","journal-title":"J Gen Virol"},{"key":"10.1016\/j.coviro.2015.03.001_bib0660","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/infdis\/164.5.835","article-title":"Antibody response to human cytomegalovirus glycoproteins gB and gH after natural infection in humans","volume":"164","author":"Rasmussen","year":"1991","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2015.03.001_bib0665","doi-asserted-by":"crossref","first-page":"7444","DOI":"10.1128\/JVI.00467-12","article-title":"Antibodies against the gH\/gL\/UL128\/UL130\/UL131 complex comprise the majority of the anti-cytomegalovirus (anti-CMV) neutralizing antibody response in CMV hyperimmune globulin","volume":"86","author":"Fouts","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2015.03.001_bib0670","doi-asserted-by":"crossref","first-page":"e59863","DOI":"10.1371\/journal.pone.0059863","article-title":"Fetal human cytomegalovirus transmission correlates with delayed maternal antibodies to gH\/gL\/pUL128\u2013130\u2013131 complex during primary infection","volume":"8","author":"Lilleri","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.coviro.2015.03.001_bib0675","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1007\/s10875-012-9739-3","article-title":"Antibodies against neutralization epitopes of human cytomegalovirus gH\/gL\/pUL128\u2013130\u2013131 complex and virus spreading may correlate with virus control in vivo","volume":"32","author":"Lilleri","year":"2012","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.coviro.2015.03.001_bib0680","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00281-014-0449-1","article-title":"Models of vertical cytomegalovirus (CMV) transmission and pathogenesis","volume":"36","author":"Weisblum","year":"2014","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.coviro.2015.03.001_bib0685","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.3390\/v6041483","article-title":"Using the nonhuman primate model of HCMV to guide vaccine development","volume":"6","author":"Deere","year":"2014","journal-title":"Viruses"},{"key":"10.1016\/j.coviro.2015.03.001_bib0690","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1128\/JVI.01809-09","article-title":"Isolation of human monoclonal antibodies that potently neutralize human cytomegalovirus infection by targeting different epitopes on the gH\/gL\/UL128\u2013131A complex","volume":"84","author":"Macagno","year":"2010","journal-title":"J Virol"},{"issue":"Pt 10","key":"10.1016\/j.coviro.2015.03.001_bib0695","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1099\/0022-1317-73-10-2693","article-title":"Glycoprotein H of human cytomegalovirus (HCMV) forms a stable complex with the HCMV UL115 gene product","volume":"73","author":"Kaye","year":"1992","journal-title":"J Gen Virol"},{"key":"10.1016\/j.coviro.2015.03.001_bib0700","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1128\/JVI.02256-09","article-title":"Human cytomegalovirus TR strain glycoprotein O acts as a chaperone promoting gH\/gL incorporation into virions but is not present in virions","volume":"84","author":"Ryckman","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2015.03.001_bib0705","doi-asserted-by":"crossref","first-page":"9680","DOI":"10.1128\/JVI.01167-13","article-title":"Comparative analysis of gO isoforms reveals that strains of human cytomegalovirus differ in the ratio of gH\/gL\/gO and gH\/gL\/UL128\u2013131 in the virion envelope","volume":"87","author":"Zhou","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2015.03.001_bib0710","doi-asserted-by":"crossref","first-page":"E4997","DOI":"10.1073\/pnas.1316517110","article-title":"Pentameric complex of viral glycoprotein H is the primary target for potent neutralization by a human cytomegalovirus vaccine","volume":"110","author":"Freed","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2015.03.001_bib0715","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrg3645","article-title":"Ribosome profiling: new views of translation, from single codons to genome scale","volume":"15","author":"Ingolia","year":"2014","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.coviro.2015.03.001_sbref0720","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.celrep.2014.07.045","article-title":"Ribosome profiling reveals pervasive translation outside of annotated protein-coding genes","volume":"8","author":"Ingolia","year":"2014","journal-title":"Cell Rep"},{"key":"10.1016\/j.coviro.2015.03.001_bib0725","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/jmr.1116","article-title":"Limitations to the structure-based design of HIV-1 vaccine immunogens","volume":"24","author":"Van Regenmortel","year":"2011","journal-title":"J Mol Recognit"},{"key":"10.1016\/j.coviro.2015.03.001_bib0730","first-page":"3","article-title":"Antigenicity and immunogenicity in HIV-1 antibody-based vaccine design","volume":"Suppl 8","author":"Kong","year":"2012","journal-title":"J AIDS Clin Res"},{"key":"10.1016\/j.coviro.2015.03.001_sbref0735","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/j.cell.2014.04.028","article-title":"Quantitative temporal viromics: an approach to investigate host\u2013pathogen interaction","volume":"157","author":"Weekes","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.coviro.2015.03.001_bib0740","doi-asserted-by":"crossref","first-page":"91ra62","DOI":"10.1126\/scitranslmed.3002234","article-title":"Rational design of a meningococcal antigen inducing broad protective immunity","volume":"3","author":"Scarselli","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.coviro.2015.03.001_bib0745","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0140-6736(10)60206-1","article-title":"Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis","volume":"375","author":"Nair","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.coviro.2015.03.001_bib0750","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/oxfordjournals.aje.a120954","article-title":"An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine","volume":"89","author":"Kapikian","year":"1969","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.coviro.2015.03.001_bib0755","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/oxfordjournals.aje.a120955","article-title":"Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine","volume":"89","author":"Kim","year":"1969","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.coviro.2015.03.001_bib0760","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1126\/science.1234914","article-title":"Structure of RSV fusion glycoprotein trimer bound to a prefusion-specific neutralizing antibody","volume":"340","author":"McLellan","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.coviro.2015.03.001_bib0765","doi-asserted-by":"crossref","first-page":"7788","DOI":"10.1128\/JVI.00555-11","article-title":"Structure of respiratory syncytial virus fusion glycoprotein in the postfusion conformation reveals preservation of neutralizing epitopes","volume":"85","author":"McLellan","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2015.03.001_sbref0770","doi-asserted-by":"crossref","first-page":"9619","DOI":"10.1073\/pnas.1106536108","article-title":"Structural basis for immunization with postfusion respiratory syncytial virus fusion F glycoprotein (RSV F) to elicit high neutralizing antibody titers","volume":"108","author":"Swanson","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2015.03.001_bib0775","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1073\/pnas.1115941109","article-title":"Neutralizing antibodies against the preactive form of respiratory syncytial virus fusion protein offer unique possibilities for clinical intervention","volume":"109","author":"Magro","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2015.03.001_bib0780","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.immuni.2012.08.012","article-title":"Human antibodies that neutralize HIV-1: identification, structures, and B cell ontogenies","volume":"37","author":"Kwong","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.coviro.2015.03.001_bib0785","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.coviro.2012.02.005","article-title":"Broadly neutralizing antibodies against influenza virus and prospects for universal therapies","volume":"2","author":"Ekiert","year":"2012","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.coviro.2015.03.001_bib0790","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1126\/science.1171491","article-title":"Antibody recognition of a highly conserved influenza virus epitope","volume":"324","author":"Ekiert","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.coviro.2015.03.001_bib0795","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1126\/science.1192819","article-title":"Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01","volume":"329","author":"Zhou","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.coviro.2015.03.001_sbref0800","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1126\/science.1234150","article-title":"Rational HIV immunogen design to target specific germline B cell receptors","volume":"340","author":"Jardine","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.coviro.2015.03.001_bib0805","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa0908492","article-title":"Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand","volume":"361","author":"Rerks-Ngarm","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coviro.2015.03.001_bib0810","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1126\/science.1151721","article-title":"Complete chemical synthesis, assembly, and cloning of a Mycoplasma genitalium genome","volume":"319","author":"Gibson","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.coviro.2015.03.001_sbref0815","doi-asserted-by":"crossref","first-page":"185ra68","DOI":"10.1126\/scitranslmed.3006368","article-title":"Synthetic generation of influenza vaccine viruses for rapid response to pandemics","volume":"5","author":"Dormitzer","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.coviro.2015.03.001_bib0820","doi-asserted-by":"crossref","first-page":"234ra55","DOI":"10.1126\/scitranslmed.3008761","article-title":"A cell culture-derived MF59-adjuvanted pandemic A\/H7N9 vaccine is immunogenic in adults","volume":"6","author":"Bart","year":"2014","journal-title":"Sci Transl Med"}],"container-title":["Current Opinion in Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625715000322?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625715000322?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T08:05:27Z","timestamp":1598861127000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879625715000322"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":82,"alternative-id":["S1879625715000322"],"URL":"https:\/\/doi.org\/10.1016\/j.coviro.2015.03.001","relation":{},"ISSN":["1879-6257"],"issn-type":[{"value":"1879-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lessons from Reverse Vaccinology for viral vaccine design","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coviro.2015.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}